PilaralisibPharmaceutical InformationUpdated on Jan 14, 2019 View more like this | Visit SHIRLEY, NY | Contact BOC Smith |
Pilaralisib, also known as XL147, is a methylbenzenesulfonamide derivative that reversibly inhibits class I PI3Ks (IC50s = 39, 36, 23, and 383 nM for p110α, δ, γ, and β, respectively), with potential antineoplastic activity.
Ordering Information
Ordering Information
